Brunner, A.D.* ; Thielert, M.* ; Vasilopoulou, C.G.* ; Ammar, C.* ; Coscia, F.* ; Mund, A.* ; Hoerning, O.B.* ; Bache, N.* ; Apalategui, A.* ; Lubeck, M.* ; Richter, S. ; Fischer, D.S. ; Raether, O.* ; Park, M.A.* ; Meier, F.* ; Theis, F.J. ; Mann, M.*
Ultra-high sensitivity mass spectrometry quantifies single-cell proteome changes upon perturbation.
Mol. Syst. Biol. 18:e10798 (2022)
Single-cell technologies are revolutionizing biology but are today mainly limited to imaging and deep sequencing. However, proteins are the main drivers of cellular function and in-depth characterization of individual cells by mass spectrometry (MS)-based proteomics would thus be highly valuable and complementary. Here, we develop a robust workflow combining miniaturized sample preparation, very low flow-rate chromatography, and a novel trapped ion mobility mass spectrometer, resulting in a more than 10-fold improved sensitivity. We precisely and robustly quantify proteomes and their changes in single, FACS-isolated cells. Arresting cells at defined stages of the cell cycle by drug treatment retrieves expected key regulators. Furthermore, it highlights potential novel ones and allows cell phase prediction. Comparing the variability in more than 430 single-cell proteomes to transcriptome data revealed a stable-core proteome despite perturbation, while the transcriptome appears stochastic. Our technology can readily be applied to ultra-high sensitivity analyses of tissue material, posttranslational modifications, and small molecule studies from small cell counts to gain unprecedented insights into cellular heterogeneity in health and disease.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Drug Perturbation ; Low-flow Lc-ms ; Proteomics At Single-cell Resolution ; Single-cell Heterogeneity ; Systems Biology
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2022
Prepublished im Jahr
HGF-Berichtsjahr
2022
ISSN (print) / ISBN
1744-4292
e-ISSN
1744-4292
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 18,
Heft: 3,
Seiten: ,
Artikelnummer: e10798
Supplement: ,
Reihe
Verlag
EMBO Press
Verlagsort
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30205 - Bioengineering and Digital Health
Forschungsfeld(er)
Enabling and Novel Technologies
PSP-Element(e)
G-503800-001
Förderungen
Graduate School of Quantitative Biosciences Munich
Marie Curie individual fellowship
Deutsches Forschungszentrum für Gesundheit und Umwelt, Helmholtz Zentrum München (German Research Center for Environmental Health, Helmholtz Zentrum München)
Novo Nordisk Fonden (NNF)
Max-Planck-Gesellschaft (MPG)
Copyright
Erfassungsdatum
2022-05-04